Company intelligence / Profile preview

GemPharmatech

Nanjing, Jiangsu, Chinaen.gempharmatech.com ↗

Ownership: Public · 688046
Employees: ~1578
Development stage: Commercial

Overview

GemPharmatech does not develop its own clinical-stage therapeutics but provides essential genetically engineered mouse models and related services that support global biomedical research and drug development. The company has one of the world’s largest libraries of KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice. No direct clinical results as it does not run its own drug programs.

Modalities: Animal model (genetically engineered mouse models)Gene editing technologyHumanized animal modelsSmall molecule (as part of pharmacology services, but not a direct product)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on GemPharmatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GemPharmatech.

Explore the full profile